RANI THERAPEUTICS HOLD

Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update

11 8月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Rani Therapeutics to Participate in August Investor Conferences

04 8月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Rani Therapeutics’ Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference

21 6月 2023 08:00:01 条件 Nasdaq GlobeNewswire

Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference

08 6月 2023 08:00:00 条件 Nasdaq GlobeNewswire

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

05 6月 2023 08:00:02 条件 Nasdaq GlobeNewswire

Rani Therapeutics to Present at the Jefferies Healthcare Conference

01 6月 2023 08:00:01 条件 Nasdaq GlobeNewswire

Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference

31 5月 2023 08:00:01 条件 Nasdaq GlobeNewswire

Rani Therapeutics Appoints Kate McKinley as Chief Business Officer

24 5月 2023 08:00:02 条件 Nasdaq GlobeNewswire

Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update

10 5月 2023 16:05:01 条件 Nasdaq GlobeNewswire

Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ

25 4月 2023 08:00:01 条件 Nasdaq GlobeNewswire

Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

11 4月 2023 08:00:01 条件 Nasdaq GlobeNewswire

Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update

22 3月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates

16 3月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment

09 1月 2023 08:30:00 条件 Nasdaq GlobeNewswire

Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update

05 1月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study

06 12月 2022 16:05:00 条件 Nasdaq GlobeNewswire

Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

10 11月 2022 16:05:01 条件 Nasdaq GlobeNewswire

Rani Therapeutics to Present at the Stifel Healthcare Conference

09 11月 2022 16:05:02 条件 Nasdaq GlobeNewswire

Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update

24 10月 2022 08:30:00 条件 Nasdaq GlobeNewswire

Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

06 9月 2022 16:05:00 条件 Nasdaq GlobeNewswire